focus -WSS

focus

author：explore 2025-10-01 02:28:31 - browse：9

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum. It’s not too late to join us virtually. Check out details here.

It’s a travel-shortened week for me, so in this newsletter, I decided to dive deep into PDS Biotech and its experimental drug for head and neck cancer. PDS is what I’d call a biotech cult stock.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Think you might have Covid

focus

hotspot

WSS

New brain studies show LSD's effects on the brain in full color

The tragedy of Johnson & Johnson’s Covid vaccine

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

A Theranos scientist

How digital therapeutics firms are pivoting after Pear's bankruptcy

Manchin plays down potential 3rd

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Hollywood unions extend contract negotiations for actors

Parkinson’s finding may lead to tests and, someday, treatments

BioMarin wins approval for gene therapy to treat hemophilia A

New brain studies show LSD's effects on the brain in full color

Medical leaders decry Supreme Court decision on affirmative action

Biden administration sends mixed signals on US soldier who crossed into North Korea

Affirmative action in medical school literally saved lives

A look at other Americans who have crossed into North Korea over the years

focus

A Theranos scientist

Robert Kennedy Jr.'s presidential campaign attracts GOP

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Copay coupons to count toward deductibles, after Biden court move

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

FDA seeking to stop procedures at two unregulated stem cell clinics

entertainment

focus

hotspot

focus